Manufacturers Life Insurance Company, The Iovance Biotherapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 311,907 shares of IOVA stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
311,907
Previous 335,513
7.04%
Holding current value
$2.83 Million
Previous $2.69 Million
8.85%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding IOVA
# of Institutions
314Shares Held
241MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$248 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$241 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$218 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$193 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$120 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.43B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...